BR0205625C1 - Nasal Gel Formulations - Google Patents

Nasal Gel Formulations

Info

Publication number
BR0205625C1
BR0205625C1 BR0205625-9A BR0205625A BR0205625C1 BR 0205625 C1 BR0205625 C1 BR 0205625C1 BR 0205625 A BR0205625 A BR 0205625A BR 0205625 C1 BR0205625 C1 BR 0205625C1
Authority
BR
Brazil
Prior art keywords
formulations
gel formulations
nasal gel
nasal
present
Prior art date
Application number
BR0205625-9A
Other languages
Portuguese (pt)
Other versions
BR0205625A (en
Inventor
Alcebiades De Mendonca Athayde
Original Assignee
Libbs Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Libbs Farmaceutica Ltda filed Critical Libbs Farmaceutica Ltda
Priority to BR0205625-9A priority Critical patent/BR0205625C1/en
Publication of BR0205625A publication Critical patent/BR0205625A/en
Publication of BR0205625C1 publication Critical patent/BR0205625C1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"FORMULAçõES NASAIS EM GEL". A presente invenção refere-se a formulações nasais em gel isentas de conservantes que compreendem sal e adicionalmente pelo menos um excipiente farmaceuticamente aceitável, água e/ou pelo menos um princípio ativo. Estas formulações são próprias para uso umidificação das cavidades nasais e na prevenção, inibição ou tratamento de problemas alérgicos ou respiratórios, particularmente rinites, sem causar irritação ou desenvolvimento de rinite medicamentosa. As formulações da presente invenção são utilizadas particularmente em tratamentos pediátricos."Nasal GEL FORMULATIONS". The present invention relates to preservative-free nasal gel formulations comprising salt and additionally at least one pharmaceutically acceptable excipient, water and / or at least one active ingredient. These formulations are suitable for use in humidifying the nasal cavities and in preventing, inhibiting or treating allergic or respiratory problems, particularly rhinitis, without causing irritation or development of drug rhinitis. The formulations of the present invention are particularly used in pediatric treatments.

BR0205625-9A 2002-12-23 2002-12-23 Nasal Gel Formulations BR0205625C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR0205625-9A BR0205625C1 (en) 2002-12-23 2002-12-23 Nasal Gel Formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0205625-9A BR0205625C1 (en) 2002-12-23 2002-12-23 Nasal Gel Formulations

Publications (2)

Publication Number Publication Date
BR0205625A BR0205625A (en) 2004-09-21
BR0205625C1 true BR0205625C1 (en) 2004-10-19

Family

ID=32968077

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0205625-9A BR0205625C1 (en) 2002-12-23 2002-12-23 Nasal Gel Formulations

Country Status (1)

Country Link
BR (1) BR0205625C1 (en)

Also Published As

Publication number Publication date
BR0205625A (en) 2004-09-21

Similar Documents

Publication Publication Date Title
PT1079806E (en) PREPARATIONS FOR THE APPLICATION OF ANTI-INFLAMMATORY, ESPECIALLY, ANTI-SEPTIC AGENTS AND / OR WOUND HEALING PROMOTION AGENTS, IN THE SUPERIOR AND / OR HEARING RESPIRATORY TRACT
ATE418324T1 (en) MUCOADHESIVE FORMULATION CONTAINING XYLOGLUCAN FOR MEDICAL DEVICES AND PHARMACEUTICAL DOSAGE FORMS
BRPI0415007A (en) method for treating, preventing, modifying or administering pain and pharmaceutical composition
BR0012590A (en) Compound, process for its preparation, pharmaceutical formulation, use of a compound, and, methods for treatment or prophylaxis of pain or discomfort, and for treatment or prophylaxis of neuropathic or central pain
BRPI0408559A (en) dispersible pharmaceutical compositions for the treatment of mastitis and optical disorders
ATE323473T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RESVERATROL AND USES THEREOF
BRPI0517891A (en) compositions comprising azelastine and methods of use thereof
IL154888A (en) Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis
BR0112356A (en) Topical Pharmaceutical Formulations and Treatment Methods
BRPI0013010B8 (en) aqueous formulation of moxifloxacin sodium chloride, process for its preparation and application of said formulation, as well as preparation for combining and applying an aqueous solution of moxifloxacin hydrochloride
BRPI0415953A (en) oral controlled release dosage formulation, method of treating a disorder, set of controlled release dosage forms and method for administering the formulation
BRPI0408655A (en) formulations comprising an active agent and cocoa powder and their use
BR0311414A (en) Therapeutic agent for an overactive bladder
BR0210013A (en) Pyrenzepine Ophthalmic Gel
ATE240717T1 (en) AQUEOUS FORMULATION FOR NASAL ADMINISTRATION
DK1343472T3 (en) Thixotropic nasal spray
BR0207866A (en) Use of flumazenil in the preparation of a drug for the treatment of cocaine addiction
BR0116653A (en) Medicinal product containing a polyamine as active substance
BR0315609A (en) Method of treating, preventing, modifying or controlling pain and pharmaceutical composition
BRPI0410374A (en) pharmaceutical composition comprising valsartan
BRPI0415651A (en) methods for treating, preventing, modifying and / or administering fibromyalgia, and for reducing or preventing an adverse effect associated with the administration of a second active ingredient in a fibromyalgia patient, and, pharmaceutical composition.
BR0115215A (en) Method for treating inflammation
BR0205625C1 (en) Nasal Gel Formulations
KR920703060A (en) Pharmaceutical Formulations
BR0009327A (en) Pharmaceutical composition for therapy of lower urinary tract symptoms

Legal Events

Date Code Title Description
B65X Notification of requirement for priority examination of patent application
B65Y Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117)
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 9/08, A61K 9/10, A61K 9/72, A61K 33/14,A61K 31/56, A61K 31/573, A61K 31/58, A61P 11/02

Ipc: A61K 9/08 (2007.01), A61K 9/10 (2007.01), A61K 9/7

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE ESTE NAO ATENDE O DISPOSTO NOS ARTIGOS 8O, 13 E 24 DA LEI 9279 DE 1996

B11Q Dismissal: the certificate of addition was not accessory to any patent, or a patent which was nominated accessory and no longer exists
B11T Dismissal of application maintained [chapter 11.20 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: